Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ruifei Xie
Hangzhou Cancer Hospital - Information Center
Hangzhou, 310002
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
42
TOTAL CITATIONS
1
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Single-Cell Sequencing Reveals CD133+CD44
-
– Originating Evolution and Stemness-Variants in
AHNAK2, PLIN4, HLA-B, ALK, CCDC92
and
ALMS1
of Human Colorectal Cancer Stem Cells
Number of pages: 43
Posted: 18 Jan 2019
Xiaoyan Zhang
,
Ling Yang
,
Wanjun Lei
,
Qiang Hou
,
Ming Huang
,
Hongfang Zhang
, Ruifei Xie,
Rongjing Zhou
,
Hongjin Wu
,
Xiaoli Zheng
,
Ying Li
,
Jing Yue
,
Zhenzhen Jiang
and
Shixiu Wu
Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Beijing Novogene Bioinformatics Technology Co., Ltd - Novogene Bioinformatics Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Information Center, Hangzhou Cancer Hospital - Department of Pathology, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute, Hangzhou Cancer Hospital - Hangzhou Cancer Institute and Hangzhou Cancer Hospital - Hangzhou Cancer Institute
Downloads
28
(958,996)
View PDF
Download
Abstract:
2.
Concurrent Chemoradiotherapy with Extended Nodal Irradiation and/or Erlotinib in Locally Advanced Esophageal Squamous Cell Cancer: Long-Term Follow-Up of a Randomized Phase 3 Trial
Number of pages: 64
Posted: 07 Jun 2019
Congying Xie
,
Zhao Jing
,
Honglei Luo
,
Wei Hu
,
Anping Zheng
,
Duojie Li
,
Lingyu Ding
,
Hongyan Zhang
,
Conghua Xie
,
Xilong Lian
,
Dexi Du
,
Ming Chen
,
Xiuhua Bian
,
Bangxian Tan
,
Bing Xia
,
Ni Zhang
, Ruifei Xie,
Qing Liu
,
Lvhua Wang
and
Shixiu Wu
Wenzhou Medical University - Second Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, The First People’s Hospital of Huaihua, Wenzhou Medical University - Taizhou Hospital of Zhejiang Province, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Bengbu Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital, Anhui Provincial Hospital, Wuhan University - Department of Radiation and Medical Oncology, Kaohsiung Medical University - Kaohsiung Medical University Hospital, Central Hospital of Lishui City, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Jiangsu Cancer Hospital, North Sichuan Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Information Center, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences - National Cancer Center and Hangzhou Cancer Hospital - Hangzhou Cancer Institute
Downloads
14
(1,118,726)
Citation
1
View PDF
Download
Abstract:
esophageal squamous cell cancer, elective nodal irradiation, erlotinib
Feedback